Insider Trading & Ownership - OPIANT PHARMACEUTICALS INC. (OPNT)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for OPIANT PHARMACEUTICALS INC.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-01-27
Sale		2023-01-31
4:22 pm		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		1,358$20.26$27,51375,339
(Direct)		View
2023-01-27
Sale		2023-01-31
4:21 pm		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		610$20.26$12,35918,751
(Direct)		View
2023-01-27
Sale		2023-01-31
4:20 pm		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		444$20.26$8,99531,990
(Direct)		View
2023-01-27
Sale		2023-01-31
4:19 pm		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		480$20.26$9,72521,548
(Direct)		View
2023-01-27
Sale		2023-01-31
4:17 pm		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		541$20.26$10,96134,248
(Direct)		View
2023-01-09
Sale		2023-01-09
5:16 pm		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		415$20.2$8,38334,789
(Direct)		View
2023-01-09
Sale		2023-01-09
5:13 pm		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		469$20.2$9,47419,361
(Direct)		View
2023-01-09
Sale		2023-01-09
5:11 pm		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		369$20.2$7,45422,028
(Direct)		View
2023-01-09
Sale		2023-01-09
5:09 pm		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		1,183$20.2$23,89776,697
(Direct)		View
2023-01-05
Sale		2023-01-05
5:07 pm		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		1,806$20.2$36,48119,830
(Direct)		View
2023-01-05
Sale		2023-01-05
5:03 pm		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		1,600$20.2$32,32035,204
(Direct)		View
2023-01-05
Sale		2023-01-05
4:59 pm		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		1,313$20.2$26,52332,434
(Direct)		View
2023-01-05
Sale		2023-01-05
4:56 pm		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		1,421$20.2$28,70422,397
(Direct)		View
2023-01-05
Sale		2023-01-05
4:52 pm		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		5,029$20.2$101,58677,880
(Direct)		View
2022-07-20
Sale		2022-07-21
4:08 pm		OPIANT PHARMACEUTICALS INC.OPNTRuth Matthew R.
Chief Commercial Officer		1,084$10.62$11,51229,916
(Direct)		View
2022-07-14
Sale		2022-07-15
4:06 pm		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		779$11.1$8,64736,804
(Direct)		View
2022-07-14
Sale		2022-07-15
4:05 pm		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		627$11.85$7,43023,818
(Direct)		View
2022-07-14
Sale		2022-07-15
4:04 pm		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		691$11.16$7,71233,747
(Direct)		View
2022-07-14
Sale		2022-07-15
4:03 pm		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		2,246$11.11$24,95382,909
(Direct)		View
2022-06-13
Sale		2022-06-15
4:30 pm		OPIANT PHARMACEUTICALS INC.OPNTSinclair Michael
Director
10% Owner		13,616$10.96$149,18819,220
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-03-02
Disposition		2023-03-03
09:27 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director		23,343$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:27 am		2019-06-13
2028-06-12		OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director		10,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:25 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTCollard Craig A
Director		55,822$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:25 am		N/A
2028-10-29		OPIANT PHARMACEUTICALS INC.OPNTCollard Craig A
Director		12,500$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:22 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTRuth Matthew R.
Chief Commercial Officer		2,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:22 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTRuth Matthew R.
Chief Commercial Officer		31,916$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:22 am		2022-07-12
2031-07-11		OPIANT PHARMACEUTICALS INC.OPNTRuth Matthew R.
Chief Commercial Officer		50,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:20 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTDaly Richard J
Director		7,800$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:20 am		2020-06-12
2029-06-11		OPIANT PHARMACEUTICALS INC.OPNTDaly Richard J
Director		12,500$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:18 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		6,667$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:18 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		87,106$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:18 am		2013-12-31
2023-12-30		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		646,700$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:16 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		2,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:16 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		30,431$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:16 am		2019-02-03
2029-01-02		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		26,200$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:13 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		2,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:13 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		23,548$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:13 am		2018-08-06
2027-02-06		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		72,200$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:10 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTSinclair Michael
Director
10% Owner		90,170$200
(Indirect)		View
2023-03-02
Disposition		2023-03-03
09:10 am		2014-06-15
2024-06-14		OPIANT PHARMACEUTICALS INC.OPNTSinclair Michael
Director
10% Owner		425,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:08 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director		28,179$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:08 am		2019-06-13
2028-06-12		OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director		10,000$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:05 am		N/A
2031-03-17		OPIANT PHARMACEUTICALS INC.OPNTLorianne Masuoka K.
Director		5,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:05 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTLorianne Masuoka K.
Director		2,000$200
(Direct)		View
2023-03-02
Option Award		2023-03-03
09:03 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		2,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:03 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		33,990$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:03 am		2021-06-01
2030-06-01		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		47,250$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:00 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTThomas Thomas T.
Director		12,375$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
09:00 am		2019-06-13
2028-06-13		OPIANT PHARMACEUTICALS INC.OPNTThomas Thomas T.
Director		10,000$00
(Direct)		View
2023-03-02
Option Award		2023-03-03
08:57 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		2,000$00
(Direct)		View
2023-03-02
Disposition		2023-03-03
08:57 am		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		36,248$200
(Direct)		View
2023-03-02
Disposition		2023-03-03
08:57 am		N/A
2029-01-02		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		52,000$00
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:07 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer		2,000$021,636
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:06 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner		6,667$085,155
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:04 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer		2,000$037,583
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:03 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer		2,000$024,445
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:02 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel		2,000$034,438
(Direct)		View
2022-06-27
Option Award		2022-06-29
4:01 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTRuth Matthew R.
Chief Commercial Officer		2,000$031,000
(Direct)		View
2022-06-14
Option Award		2022-06-14
5:00 pm		N/A
N/A		OPIANT PHARMACEUTICALS INC.OPNTCollard Craig A
Director		2,000$055,822
(Direct)		View
Goto 0, 1, 2, 3, Next